Latest news and press releases about ResMed Inc. (RMD): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service.
Price
| Price | $222.86 |
| Market Cap | $32.3B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 21.05 |
| Price / Book | 4.81 |
| EV / EBITDA | 12.84 |
| Dividend Yield | 1.12% |
Profitability
| Return on Equity | 23.13% |
| Return on Invested Capital | 19.11% |
| Return on Assets | 16.99% |
| Gross Margin | 61.16% |
| Operating Margin | 33.48% |
| Net Margin | 26.94% |
Related companies: A · ALC · BDX · CAH · GEHC · HLN · HUM
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of RMD: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks